Global Propofol API Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Propofol API market size will reach  Million USD in 2025 and is projected to reach  Million USD by 2032, with a CAGR of  % (2025-2032). Notably, the China Propofol API market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Propofol API refers to the active pharmaceutical ingredient (API) used in the formulation of propofol, a widely used intravenous anesthetic agent. The API is the key component responsible for the pharmacological effects of the drug. In the case of propofol, the API is 2,6-diisopropylphenol, also known as propofol or its chemical name, 1,1,1,3,3,3-hexafluoro-2-propanol. Propofol API is typically manufactured through chemical synthesis processes and must meet strict quality standards set by regulatory authorities to ensure its safety, efficacy, and purity. Once produced, propofol API is then formulated into injectable solutions for clinical use. These formulations often include additional ingredients such as emulsifiers, stabilizers, and preservatives to create a suitable dosage form for intravenous administration. Propofol API is essential in anesthesia, sedation, and critical care medicine, playing a crucial role in surgeries, medical procedures, and intensive care settings.

The major global  manufacturers of Propofol API include Bachem, Curia, SI Group, Neuland Laboratories, Harman Finochem, Midas Pharma, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Xi’an Libang Pharmaceutical, Beijing Sciecure Pharmaceutical, Jiangsu Nhwa Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Propofol API. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Propofol API market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Propofol API market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Propofol API industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Propofol API Include:

Bachem

Curia

SI Group

Neuland Laboratories

Harman Finochem

Midas Pharma

Guangdong Jiabo Pharmaceutical

Sichuan Biokin Pharmaceutical

Xi’an Libang Pharmaceutical

Beijing Sciecure Pharmaceutical

Jiangsu Nhwa Pharmaceutical

Propofol API Product Segment Include:

Purity above 99.5%

Purity below 99.5%

Propofol API Product Application Include:

Propofol Injectable Emulsion

Propofol MCT/LCT Injectable Emulsion

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Propofol API Capacity and Production Analysis

Chapter 3: Global Propofol API Industry PESTEL Analysis

Chapter 4: Global Propofol API Industry Porter's Five Forces Analysis

Chapter 5: Global Propofol API Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global Propofol API Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global Propofol API Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, Propofol API Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources